학술논문
Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase γ inhibitor for the treatment of inflammatory diseases
Document Type
Article
Author
Source
In Bioorganic & Medicinal Chemistry 15 December 2013 21(24):7578-7583
Subject
Language
ISSN
0968-0896